Company · founded 1994
Corixa Corporation
Seattle, United States · coulterpharm.com
Part of GlaxoSmithKline (United Kingdom)
- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 172
- Scientists listed
- 0
- Grants since 2016
- 1
Grants received
2017–2019 · research · R43
Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites
Robert Diluccio · Corixa Corporation · funded by National Institutes of Health